Pharma / Medical

Nosak Healthcare is the pharmaceutical arm of Nosak Group. Established in 2008, it is affiliated to major global players in the healthcare industry in Europe and South East Asia. It also engages in local contract manufacturing of some of its products. We are Nosak Group – a proudly Nigerian industrial conglomerate with diversified interests in the Nigerian economy. We lead the way in our fields of play, which embraces the West African sub region. The Nosak Group is made of subsidiaries that benefit from strong regional and international alliances. We are administered in the best traditions of entrepreneurship. Our distinguishing virtues are built upon a strict adherence to quality, product integrity and an exceptional commitment to customer satisfaction. We are constantly seeking opportunities to add value to the prosperity of the country, its people and all our stakeholders. Thinking locally but acting globally, we serve tomorrow’s markets, today. In 1984, in the city of Kano, a seed of entrepreneurship was sown. From a retail shop selling soft drinks and snacks, the seed grew into retail trade, ice block manufacturing, transportation, distribution, importation until finally, this seed became Nosak Group. Today, the Nosak group is a key player in the Nigerian economy, offering vital services in retail, manufacturing, logistics, finance, agriculture, real estate, international trade, petroleum and health care thanks to a deep understanding of the Nigerian market and a network of local and international alliances. As many chapters make a good storybook, our subsidiaries make up crucial chapters of the story of the Nosak group and they make it a great story to tell. It all started with Nosak Agencies Limited in 1984, the pioneer company in the group which specialized in the importation and marketing of ethanol. Today, it has grown and evolved into the investment arm of Nosak group. The second chapter of the Nosak story is a somewhat natural progression to the manufacturing of ethanol and other industrial and consumer based chemicals through Nosak Distilleries. Incorporated in 2001, today, Nosak Distilleries is the largest manufacturer of ethanol in Nigeria with a storage facility of 24 million liters and currently controls more than 65% of the domestic supply market. It owns and operates a modern distillery for ethanol production at Amuwo Odofin Industrial Layout in Lagos. With an installed capacity of 400,000 litres of ethanol per day, Nosak Distilleries Limited expects to meet 70% of the local demand for ethanol and other industrial chemicals in Nigeria. To further capture the market for industrial chemicals, Zex Standard Chemicals Limited was established to import and trade chemicals like ethanol and other pharmaceutical raw materials. With facilities around Lagos, Zex Standard Chemicals is positioned to be the foremost provider of pharmaceutical chemicals in the country.

Pharmaceutical Technology is the only online platform focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals -  from senior executives to manufacturing managers and heads of procurement - require to stay on top of their field. Our international scope allows us to examine all pharmaceutical markets closely, from biotechnology to therapeutics, vaccines and more. When you combine this with one of the most comprehensive and detailed listings of pharmaceutical equipment suppliers, products and services, free white paper downloads and company press releases, you can see why Pharmaceutical Technology is the key point of reference for the pharma industry. Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format. Produced by a team of experienced editors and contributors, this monthly magazine brings together the latest insights and innovations from across the industry, including new discoveries, R&D and clinical trials, manufacturing technologies and supply chain management, as well as insiders’ views and in-depth analysis of the latest market and investment trends and regulatory changes affecting the industry.

Forrester Pharma and Lamar International are registered pharmaceutical companies focussed on providing innovative healthcare at affordable prices. We focus on successful product launches and swift generic entries, led by our vision to broaden access to quality healthcare in an affordable and efficient manner. People are the success behind any venture and Forrester Pharma and Lamar International have recruited a strong management team that has well-established relationships with the Governmental and Regulatory Authorities, Private Funders and Healthcare Professionals in South Africa. These relationships have been born from the team’s extensive industry experience which have also resulted in significant intellectual property relating to consumer and customer partnerships. The team is led by Jerome Smith, the founder of one of the first South African generic pharmaceutical companies, which he led to become one of the largest pharmaceutical companies in South Africa. Jerome is a lifelong pharmaceutical man and founder of Medpro Pharmaceutica in 1993, which later became known as Cipla Medpro. One of the first South African generic pharmaceutical companies was formed through strategically aligning his company with Cipla India. Under his leadership he led Cipla Medpro to becoming South Africa’s third largest pharmaceutical company by value. Through organic growth the company expanded from 2 employees and a humble beginning in 1993 to an organization of 720 employees in 18 years. Jerome’s vision was instrumental in introducing South Africa to Indian Pharmaceutical expertise. Jerome left Cipla Medpro in September 2012 and pursued a new venture – Forrester Pharma and Lamar International which are independent and privately owned start-up companies.

At NPS we are passionate about nutrition, health and helping our clientele attain a balanced outlook when it comes to wellness. We undertake the trading of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) both locally and internationally. We are also producers and contract packers of affordable, nutritionally balanced product ranges that ultimately promote improved health and wellness for all. NPS’s mission is to promote wellness and we pride ourselves on being solutions-driven. NPS is focused on finding synergy with our clients and not only meeting our clients needs & expectations, but also exceed them whenever possible. NPS has exclusive contacts and established relationships with many cosmetic related product manufacturers and ingredient suppliers internationally. We are continuously extending our offerings and finding new products through travel and trade shows. Allow NPS to find that niche item to extend your range or break into a potential market. A diverse range of powdered ingredients, supplements, capsules, creams etc. is already available and through our network anything you need to grow your brand can be sourced. ACTIVE PHARMACEUTICAL INGREDIENTS (API) Our API Trading Division has more than 30 years of experience worldwide and recently relocated from South America to our offices in Cape Town, South Africa. Specialising in the production, sourcing, trading and distribution of key API's and FDF's around the world, this department uses an extensive network of important contacts and relationships built up over decades, to provide clients with world class service. The service includes: Sourcing of specific products Ensuring specifications comply with client's requirements Sourcing and providing of all regulatory documents Storage Shipping

The Fagron compounding pharmacies in Cape Town (Rausa-kem), Johannesburg (Dynaceuticals) and George (Mar-Kem) have served doctors and patients since 1995. Fagron South Africa is well established as a respected partner and leader in the pharmaceutical compounding industry. Fagron entered the South African market through acquisition of key compounding pharmacies in Cape Town, George and Johannesburg. In 2014, Fagron acquired Dynaceuticals, a compounding pharmacy in Gauteng, which is headed by three dynamic professionals. In 2015, Fagron acquired Rausa-kem, which is headed by Professor Reinhard Uebel with 20 years of sterile compounding experience, Reakiri, the marketing and sales arm of Rausa-kem, and MarKem, a sterile compounding pharmacy in George. This powerful combination has created a unique, national organisation serving both doctors and patients all over the country. Our team of pharmacists is headed by Professor Reinhard Uebel, who graduated with a BPharm in 1982 and completed his PhD in 1994. He lectured pharmacology at the University of Stellenbosch and Pharmaceutics at UWC. Professor Uebel is the author of a number of research publications. Fagron South Africa compounds high-quality, cost-effective, customised, proven formulations of medications that are not available from a pharmaceutical drug company. Compounded medications are prepared as per the doctor’s prescription and formulated in the exact strength and form needed by the patient. This allows doctors and pharmacists to customize a medication that meets the patient’s specific requirements. Historically, all medicines were compounded, but with mass-produced drugs this is no longer the case. A ‘one-size-fits-all’ approach does not, however, always meet the needs of patients, and compounding pharmacists provide a solution for this. Modern technology and innovation has revived the historic art and science of compounding pharmaceuticals.